• PO Box 450 Mawson ACT, 2607 Australia

  • 02 6260 4022

2019 China Regulatory and Supply Chain Seminar Wrap Up


2019 China Regulatory and Supply Chain Seminar Wrap Up

Complementary Medicines Australia (CMA) in association with the China Chamber of Commerce for the Import and Export of Medicines and Health Products (CCCMHPIE) were pleased to host 100 delegates for the inaugural China Regulatory and Supply Chain Seminar on the 8th of October 2019. The seminar aimed to promote greater knowledge and engagement between our professional networks.

Designed to provide valuable and practical insights into effective marketing and trading to China. The line-up of presenters boasted industry insiders and experts in trading, regulation and distribution.

Presentations from the seminar have been made available to delegates via email. If you did not receive this email and would like to view the presentations, please contact us.

Here’s a synopsis of the speakers and their presentations.

Mr Joe Zhou, Chairman and CEO TSI Pharmaceuticals, Introduction to the TSI Group
The TSI Group was founded over 23 years ago explained Joe Zhou. The TSI Group is a leading international manufacturer that offers high-quality, internationally competitive pricing and market-leading innovations. This award-winning company has earned seven international certifications including TGA, US FDA, CFDA, and HPRA. Mr Zhou explained that the company offers a fully integrated supply chain with 360° quality control and traceability from farm/source to TSI’s own factories to Customer. Products are made to pharmaceutical grade he said.

Mr Ligang Zhang, President, China Gate Technical Service Company
Mr Ligang Zhang’s presentation covered policy, regulations and market trend regarding access to China’s nutrition and health industry.
He went on to outline the National Nutrition Program, field classification of the Nutrition and Health Industry, trends in the nutrition and health, special food registration and filing of foods used in healthcare. Mr Zhang finished with an outline of the registration of special foods including foods for special medical purposes and infant formula milk powder.

Ms Yin Zhang, Vice President, Avida Health ANZ Market
In her presentation, Ms Zhang outlined dynamic product Innovation trends globally and in the Asia-Pacific region.
She explained that trends are driven by shifts in consumer needs due to globalisation, science and technology as well as an ageing population.
Detailing the nutricosmetics market in China Ms Zhang confirmed that this was a fast growing area with an expected CAGR of 11.5% per year (much faster than traditional cosmetics) The nutricosmetics products market size expected to grow at 43% per year and in China, market size is estimated to be RMB 23.8 billion by 2022.
Rapid growth, she said, is not only due to consumer recognition of product effects, but also due to the growing trend of green consumption.

Justin Howden, Group Head, Global Government Affairs and Industry Development at The H&H Group
Mr Howden detailed Swisse’s remarkable development in China. In 2018, a financial highlight for the company was the revenue growth in China by 63% to AUD320 million.
Success, he said, was largely due to developing deep insights into the Chinese consumer and how they shop as well as tailoring products and marketing and creating new consumer segments.
Building strong relationships with key sales and distribution partners, media and consumers as KOLs was key, he said. Swisse has built and maintained a leading position in the Australian market by building consumer trust said Mr Howden.

Mr Richard Zhang, President, Sinobo Supply Chain Management Co. Ltd.
Effective Supply Chain Management of Cross-Border E-Commerce was the focus of Mr Zhang’s presentation.
He detailed the management of channels, logistic and capital management. He explained the importance of flagship stores, plus the importance of the correct approaches to internal marketing in E-channels.
The challenge of choosing a supply chain company and their role in becoming a strategic partner was explained. An integrated and unified supply chain company to avoid multiple subcontracting would provide the advantages of cooperation, complementary coordination and mutual development he said. 

Jack Lu, Australian Trade and Investment Commission
In a lively and informative presentation, Mr Lu explained a number of successful ways to approach cross border e-commerce China
The ecosystem in China involves unique sales channels, marketing strategy, logistic solutions and payment gateways he explained.
Mr Lu went on to detail the most used marketing tactics in China. He finished by demonstrating the existing Austrade Resources available that exist to support Australian trade in China.

Matthew McDougall, President, Australia China Daigou Association
Mr McDougall applied his unique and extensive experience to share with the audience just what exactly the Daigou phenomenon is. The name for a group of Chinese who are residing abroad, buying on behalf of their families and friends back in China. In 2016, the Daigou business was worth an estimated A$800M in Australia and according to research conducted by a Chinese media lab the market could grow to a jaw dropping 150 billion USD globally by 2018. The number of Daigou are said to be 70,000-80,000 in Australia and 15,000 -18,000 in New Zealand.
Mr McDougall ended by saying that while Daigou is not a complete cross border solution, for many brands, they are a critical success factor in a China strategy.

CMA and CCCMHPIE would like to extend our gratitude to the speakers on the seminar program, event sponsors TSI Pharmaceuticals and China Gate and to the delegates who travelled from China to attend the event.

Copyright © 2019 Complementary Medicines Australia. All rights reserved.

Powered by Wild Apricot Membership Software